Murat Kartal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Murat Kartal has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Ebrar İnAl
Department of Pharmacognosy, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Türkiye
4 shared publications - Bahar Gok
Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Yildiz Technical University, Istanbul, Turkey
3 shared publications - Ebru Özdemir Nath
Department of Pharmacognosy, Faculty of Pharmacy, Altınbaş University, Bakırköy Health Campus, 34145 İstanbul, Türkiye
3 shared publications - Yasemin Budama-Kilinc
Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Yildiz Technical University, Istanbul, Turkey
3 shared publications - Yıldız Özsoy
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Türkiye
3 shared publications - Şeyma Ulusoy
BEZMI ALEM FOUNDATION UNIVERSITY, FACULTY OF PHARMACY, DEPARTMENT OF PROFESSIONAL PHARMACEUTICAL SCIENCES, DEPARTMENT OF PHARMACOGNOSY
3 shared publications
Latest Publications
- Open Access
- 13 April 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (4) , 613
Berberine as a Multifunctional Adjuvant in Cancer Therapy: Mechanistic Insights, Nanotechnological Strategies, and Translational Challenges
Multidrug resistance (MDR) and chemotherapy-associated toxicity remain major challenges limiting the success of cancer treatments. In this context, berberine (BBR), an isoquinoline derivative belonging to the barberry family, has emerged as a promising adjuvant that can enhance the efficacy of chemotherapy while potentially mitigating its side effects. The findings indicate that berberine enhances the therapeutic effect of several drugs, such as doxorubicin, cisplatin, tamoxifen, and 5-fluorouracil, through multiple mechanisms including the inhibition of ABC transporters, regulation of autophagy, and synergistic enhancement of reactive oxygen species generation. Advanced pharmaceutical and nanotechnological formulations, including cyclodextrin complexes, solid dispersions, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, chitosan-based systems, and inorganic nanoplatforms, have demonstrated significant improvements in the solubility, stability, cellular uptake, and oral bioavailability of berberine. However, knowledge gaps remain regarding optimal dosage determination, safety assessment in combination therapy, and establishing efficacy in large-scale clinical trials. Incorporating berberine into combination therapy strategies may improve treatment outcomes, overcome drug resistance, and potentially reduce the toxic burden associated with chemotherapy. Therefore, this review provides a comprehensive analytical framework for berberine’s potential as an adjuvant, elucidates its mechanistic synergistic interactions with standard therapies, explores pharmaceutical strategies to overcome bioavailability limitations, and suggests future research avenues to further its clinical development.
- 13 April 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (4) , 613
Open AccessBerberine as a Multifunctional Adjuvant in Cancer Therapy: Mechanistic Insights, Nanotechnological Strategies, and Translational Challenges
Multidrug resistance (MDR) and chemotherapy-associated toxicity remain major challenges limiting the success of cancer treatments. In this context, berberine (BBR), an isoquinoline derivative belonging to the barberry family, has emerged as a promising adjuvant that can enhance the efficacy of chemotherapy while potentially mitigating its side effects. The findings indicate that berberine enhances the therapeutic effect of several drugs, such as doxorubicin, cisplatin, tamoxifen, and 5-fluorouracil, through multiple mechanisms including the inhibition of ABC transporters, regulation of autophagy, and synergistic enhancement of reactive oxygen species generation. Advanced pharmaceutical and nanotechnological formulations, including cyclodextrin complexes, solid dispersions, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, chitosan-based systems, and inorganic nanoplatforms, have demonstrated significant improvements in the solubility, stability, cellular uptake, and oral bioavailability of berberine. However, knowledge gaps remain regarding optimal dosage determination, safety assessment in combination therapy, and establishing efficacy in large-scale clinical trials. Incorporating berberine into combination therapy strategies may improve treatment outcomes, overcome drug resistance, and potentially reduce the toxic burden associated with chemotherapy. Therefore, this review provides a comprehensive analytical framework for berberine’s potential as an adjuvant, elucidates its mechanistic synergistic interactions with standard therapies, explores pharmaceutical strategies to overcome bioavailability limitations, and suggests future research avenues to further its clinical development.
- Open Access
- 16 March 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (11) , e06319
Phenolic Profile Investigation and Effect of Phedimus stolonifer (S.G. Gmel.)'t Hart on Urease and Serine Proteases
This study aimed to evaluate the in vitro inhibitory activities of Phedimus stolonifer (S.G. Gmel.)'t Hart against urease, chymotrypsin, and trypsin enzymes. Among the tested samples, the n ‐butanol sub‐extract (PS‐BuOH) exhibited the strongest chymotrypsin and trypsin inhibitory activities, with IC 50 values of 78.82 and 22.19 µg/mL, respectively. The most potent urease inhibitory effects were observed in the ethanol extract (PS‐EtOH) and the ethyl acetate sub‐extract (PS‐EtOAc), with IC 50 values of 44.29 and 35.24 µg/mL, respectively. The phenolic compositions of the sub‐extracts were analyzed using liquid chromatography‐high resolution mass spectrometry (LC‐HRMS). Vanillic acid was detected at 55.155 mg/100 g in the hexane sub‐extract (PS‐Hex). The dichloromethane sub‐extract (PS‐CH 2 Cl 2 ) contained vanillic acid (2865.567 mg/100 g), p ‐coumaric acid (1157.474 mg/100 g), and rhamnocitrin (171.160 mg/100 g), while the PS‐EtOAc included (–)‐epicatechin gallate (73.918 mg/100 g), vanillic acid (36.263 mg/100 g), and caffeic acid (14.897 mg/100 g). The PS‐BuOH was found to be rich in vanillic acid (7.912 mg/100 g), rhamnocitrin (3.119 mg/100 g), and chrysoeriol (1.495 mg/100 g). The aqueous sub‐extract (PS‐Rw) predominantly contained p ‐coumaric acid (39.201 mg/100 g) and vanillic acid (18.041 mg/100 g). Consistent with their high phenolic and flavonoid content, the extracts and sub‐extracts demonstrated notable antioxidant activities.
- 16 March 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (11) , e06319
Open AccessPhenolic Profile Investigation and Effect of Phedimus stolonifer (S.G. Gmel.)'t Hart on Urease and Serine Proteases
This study aimed to evaluate the in vitro inhibitory activities of Phedimus stolonifer (S.G. Gmel.)'t Hart against urease, chymotrypsin, and trypsin enzymes. Among the tested samples, the n ‐butanol sub‐extract (PS‐BuOH) exhibited the strongest chymotrypsin and trypsin inhibitory activities, with IC 50 values of 78.82 and 22.19 µg/mL, respectively. The most potent urease inhibitory effects were observed in the ethanol extract (PS‐EtOH) and the ethyl acetate sub‐extract (PS‐EtOAc), with IC 50 values of 44.29 and 35.24 µg/mL, respectively. The phenolic compositions of the sub‐extracts were analyzed using liquid chromatography‐high resolution mass spectrometry (LC‐HRMS). Vanillic acid was detected at 55.155 mg/100 g in the hexane sub‐extract (PS‐Hex). The dichloromethane sub‐extract (PS‐CH 2 Cl 2 ) contained vanillic acid (2865.567 mg/100 g), p ‐coumaric acid (1157.474 mg/100 g), and rhamnocitrin (171.160 mg/100 g), while the PS‐EtOAc included (–)‐epicatechin gallate (73.918 mg/100 g), vanillic acid (36.263 mg/100 g), and caffeic acid (14.897 mg/100 g). The PS‐BuOH was found to be rich in vanillic acid (7.912 mg/100 g), rhamnocitrin (3.119 mg/100 g), and chrysoeriol (1.495 mg/100 g). The aqueous sub‐extract (PS‐Rw) predominantly contained p ‐coumaric acid (39.201 mg/100 g) and vanillic acid (18.041 mg/100 g). Consistent with their high phenolic and flavonoid content, the extracts and sub‐extracts demonstrated notable antioxidant activities.
- 25 August 2025
- Published by S. Karger AG in Complementary Medicine Research
- Vol. 32 (5) , 376-386
Physicians’ and Pharmacists’ Knowledge, Thoughts, and Attitudes of Homeopathy: A Comparative Survey in Türkiye
Background: Homeopathy, included in traditional and complementary medicine (TCM), is defined as a complementary treatment that aims to improve health through personalized therapy. Physicians and pharmacists play a crucial role in the practice of homeopathy and the delivery of homeopathic medicinal products to the public in Türkiye. This study aimed to evaluate the knowledge, thoughts, and attitudes of physicians and pharmacists on homeopathy in accordance with Turkish regulations. Methods: This descriptive study was carried out on physicians and pharmacists via a web-based questionnaire method. The survey form includes three sections and twenty-three questions. Participants received the survey form via Facebook, Instagram, X (Twitter), and LinkedIn. A total of 475 questionnaires that met the data quality criteria were included in the study. The analysis of the data was performed with the SPSS 23.0 statistical program, with a statistical significance level set at p < 0.05. Results: The study population included 70.3% (n = 334) pharmacists and 29.7% (n = 141) physicians. The study’s results demonstrate that 86.5% of participants had heard of the concept of homeopathy. It was found that a higher rate of hearing about homeopathy was associated with being a pharmacist (OR: 31.5, p = 0.000) and having 10 years or more of professional experience (OR: 7.274, p = 0.000). The participants had correct knowledge about the definition and basic principles of homeopathy. The respondents lacked knowledge on certain aspects of the regulation of homeopathic practice in Türkiye. The primary source of information for pharmacists was undergraduate courses (n = 185, 58.2%), but for physicians, it was social media/television (n = 41, 50.0%). Of the participants, 70.1% (n = 288) thought that homeopathy needs to be incorporated into the undergraduate curriculum, and 91.7% of participants thought that further scientific research on homeopathy is required. Conclusion: Homeopathy courses should be integrated into undergraduate education to improve the awareness of healthcare professionals. Furthermore, the organization of seminars and training courses would enhance their knowledge of the relevant subject.
- 25 August 2025
- Published by S. Karger AG in Complementary Medicine Research
- Vol. 32 (5) , 376-386
Physicians’ and Pharmacists’ Knowledge, Thoughts, and Attitudes of Homeopathy: A Comparative Survey in Türkiye
Background: Homeopathy, included in traditional and complementary medicine (TCM), is defined as a complementary treatment that aims to improve health through personalized therapy. Physicians and pharmacists play a crucial role in the practice of homeopathy and the delivery of homeopathic medicinal products to the public in Türkiye. This study aimed to evaluate the knowledge, thoughts, and attitudes of physicians and pharmacists on homeopathy in accordance with Turkish regulations. Methods: This descriptive study was carried out on physicians and pharmacists via a web-based questionnaire method. The survey form includes three sections and twenty-three questions. Participants received the survey form via Facebook, Instagram, X (Twitter), and LinkedIn. A total of 475 questionnaires that met the data quality criteria were included in the study. The analysis of the data was performed with the SPSS 23.0 statistical program, with a statistical significance level set at p < 0.05. Results: The study population included 70.3% (n = 334) pharmacists and 29.7% (n = 141) physicians. The study’s results demonstrate that 86.5% of participants had heard of the concept of homeopathy. It was found that a higher rate of hearing about homeopathy was associated with being a pharmacist (OR: 31.5, p = 0.000) and having 10 years or more of professional experience (OR: 7.274, p = 0.000). The participants had correct knowledge about the definition and basic principles of homeopathy. The respondents lacked knowledge on certain aspects of the regulation of homeopathic practice in Türkiye. The primary source of information for pharmacists was undergraduate courses (n = 185, 58.2%), but for physicians, it was social media/television (n = 41, 50.0%). Of the participants, 70.1% (n = 288) thought that homeopathy needs to be incorporated into the undergraduate curriculum, and 91.7% of participants thought that further scientific research on homeopathy is required. Conclusion: Homeopathy courses should be integrated into undergraduate education to improve the awareness of healthcare professionals. Furthermore, the organization of seminars and training courses would enhance their knowledge of the relevant subject.
- Open Access
Secondary Metabolite Profiling of Satureja aintabensis P.H. Davis and Satureja spicigera (K. Koch) Boiss. by LC-HRMS and Evaluation of Antioxidant and Anticholinergic Activities
In this study, phenolic compounds of methanol extracts obtained from the leaves and branches of Satureja aintabensis P.H. Davis and Satureja spicigera (K. Koch) Boiss. species were determined as mg/kg extract using the liquid chromatography high resolution mass spectrometry technique. The in vitro inhibitory effects of these extracts against enzymes associated with neurodegenerative Alzheimer’s disease (AD) were also evaluated. The relationship between secondary metabolite structures and biological activities was discussed. The major components of S. aintabensis were determined as hesperidin (6.465% of the extract; 64.65 g/kg), syringic acid (5.964% of the extract; 59.64 g/kg), rosmarinic acid (5.248% of the extract; 52.48 g/kg) and naringenin (0.395% of the extract; 3946.84 mg/kg), while syringic acid (3.081% of the extract; 30.81 g/kg), rosmarinic acid (2.757% of the extract; 27.57 g/kg), hesperidin (1.723% of the extract; 17.23 g/kg), and luteolin-7-O-rutinoside (1.682% of the extract; 16.82 g/kg) were determined in S. spicigera. AChE and BChE enzyme inhibition of the extracts were analyzed. The species showed moderate inhibition against AChE enzyme and low inhibition against BChE enzyme. The antioxidant properties of both plant extracts were evaluated by measuring three radical scavenging capacities and the ability to reduce Fe3+, and Cu2+ ions. S. aintabensis showed better antioxidant capacity in all methods except DPPH scavaging assay. These data clearly show that both species, especially S. aintabensis, have emerged as a new and important natural source of hesperidin, syringic acid and rosmarinic acid and an antioxidant agent for pharmaceutical and nutraceutical applications.
Open AccessSecondary Metabolite Profiling of Satureja aintabensis P.H. Davis and Satureja spicigera (K. Koch) Boiss. by LC-HRMS and Evaluation of Antioxidant and Anticholinergic Activities
In this study, phenolic compounds of methanol extracts obtained from the leaves and branches of Satureja aintabensis P.H. Davis and Satureja spicigera (K. Koch) Boiss. species were determined as mg/kg extract using the liquid chromatography high resolution mass spectrometry technique. The in vitro inhibitory effects of these extracts against enzymes associated with neurodegenerative Alzheimer’s disease (AD) were also evaluated. The relationship between secondary metabolite structures and biological activities was discussed. The major components of S. aintabensis were determined as hesperidin (6.465% of the extract; 64.65 g/kg), syringic acid (5.964% of the extract; 59.64 g/kg), rosmarinic acid (5.248% of the extract; 52.48 g/kg) and naringenin (0.395% of the extract; 3946.84 mg/kg), while syringic acid (3.081% of the extract; 30.81 g/kg), rosmarinic acid (2.757% of the extract; 27.57 g/kg), hesperidin (1.723% of the extract; 17.23 g/kg), and luteolin-7-O-rutinoside (1.682% of the extract; 16.82 g/kg) were determined in S. spicigera. AChE and BChE enzyme inhibition of the extracts were analyzed. The species showed moderate inhibition against AChE enzyme and low inhibition against BChE enzyme. The antioxidant properties of both plant extracts were evaluated by measuring three radical scavenging capacities and the ability to reduce Fe3+, and Cu2+ ions. S. aintabensis showed better antioxidant capacity in all methods except DPPH scavaging assay. These data clearly show that both species, especially S. aintabensis, have emerged as a new and important natural source of hesperidin, syringic acid and rosmarinic acid and an antioxidant agent for pharmaceutical and nutraceutical applications.
- 25 June 2025
- Published by ACG Publications in Records of Natural Products
- Vol. 19 (S) , 400-427
Review on the Biological Activities and Phytochemistry of the Genus Satureja
The genus of Satureja species belongs to the Lamiaceae family and has been used as culinary spice and condiment as well as in traditional medicine for the treatment of a variety of diseases such as gastrointestinal system disorders including cramps, nausea, indigestion, and diarrhea and respiratory system disorders, skin disorders, pain and inflammation. The genus is represented by 61 taxa worldwide, and 17 taxa are distributed in Türkiye. This paper reviews biological activity and phytochemical constituents of Satureja species. The related scientific and books, journals, articles and Pubmed, Scopus, Science Direct and Google Scholar databases were searched using the keyword “Satureja” related to the studies on the phytochemistry, secondary metabolites, essential oil, volatiles, phytochemisrty and/or biological activities were evaluated and reviewed. As a result of this current review, current data on the Satureja genus was assessed mainly for various biological activities. Especially the anticholinergic, anti-antioxidant, cytotoxic, antimicrobial, anti-inflammatory, analgesic/antinociceptive, larvicidal, and insecticide activities of the genus are remarkable. However, only a limited number of the current literature focused on the isolated active compounds. As a result, the genus Satureja presents a significant potential as a natural resource for the development of agricultural products for new pharmaceuticals, cosmetics, veterinary products, and foods of different sectors. New research and in vivo bioactivity evaluations may open new avenues for the valorisation of Satureja preparations especially in the health and cosmetic industries.
- 25 June 2025
- Published by ACG Publications in Records of Natural Products
- Vol. 19 (S) , 400-427
Review on the Biological Activities and Phytochemistry of the Genus Satureja
The genus of Satureja species belongs to the Lamiaceae family and has been used as culinary spice and condiment as well as in traditional medicine for the treatment of a variety of diseases such as gastrointestinal system disorders including cramps, nausea, indigestion, and diarrhea and respiratory system disorders, skin disorders, pain and inflammation. The genus is represented by 61 taxa worldwide, and 17 taxa are distributed in Türkiye. This paper reviews biological activity and phytochemical constituents of Satureja species. The related scientific and books, journals, articles and Pubmed, Scopus, Science Direct and Google Scholar databases were searched using the keyword “Satureja” related to the studies on the phytochemistry, secondary metabolites, essential oil, volatiles, phytochemisrty and/or biological activities were evaluated and reviewed. As a result of this current review, current data on the Satureja genus was assessed mainly for various biological activities. Especially the anticholinergic, anti-antioxidant, cytotoxic, antimicrobial, anti-inflammatory, analgesic/antinociceptive, larvicidal, and insecticide activities of the genus are remarkable. However, only a limited number of the current literature focused on the isolated active compounds. As a result, the genus Satureja presents a significant potential as a natural resource for the development of agricultural products for new pharmaceuticals, cosmetics, veterinary products, and foods of different sectors. New research and in vivo bioactivity evaluations may open new avenues for the valorisation of Satureja preparations especially in the health and cosmetic industries.
- 28 May 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e00466
Anti‐lipoxygenase Evaluation of Different Achillea sp. Extracts
In this present work, in vitro lipoxygenase (LOX) inhibitory activities of methanol extracts and different fractions of six Achillea species [A. biebersteinii, A. millefolium, A. cappadocica, A. wilhelmsii, A. setacea, and A. nobilis subsp. neilreichii] were evaluated. A microplate‐based spectrophotometric method was utilized for the LOX assay. The phenolic composition was analyzed using the liquid chromatography‐high resolution mass spectrometer (LC‐HRMS). As a result, the A. biebersteinii (Malatya locality) ethyl acetate fraction showed the highest lipoxygenase inhibitory activity (72.9% inhibition), followed by the A. cappadocica ethyl acetate fractions with 66.9% and 60.4% inhibition, respectively. The phytochemical LC‐HRMS analyses revealed that the active constituents of the studied fractions were vanillic acid, hyperoside, p‐coumaric acid, quercetin, and chrysoeriol. The findings showed the active bioassay‐directed fractions, as well compounds to the best of our knowledge for the first time, suggesting further future biological, pharmacological, and toxicological evaluations both in vitro and in vivo.
- 28 May 2025
- Published by Wiley in Chemistry & Biodiversity
- p. e00466
Anti‐lipoxygenase Evaluation of Different Achillea sp. Extracts
In this present work, in vitro lipoxygenase (LOX) inhibitory activities of methanol extracts and different fractions of six Achillea species [A. biebersteinii, A. millefolium, A. cappadocica, A. wilhelmsii, A. setacea, and A. nobilis subsp. neilreichii] were evaluated. A microplate‐based spectrophotometric method was utilized for the LOX assay. The phenolic composition was analyzed using the liquid chromatography‐high resolution mass spectrometer (LC‐HRMS). As a result, the A. biebersteinii (Malatya locality) ethyl acetate fraction showed the highest lipoxygenase inhibitory activity (72.9% inhibition), followed by the A. cappadocica ethyl acetate fractions with 66.9% and 60.4% inhibition, respectively. The phytochemical LC‐HRMS analyses revealed that the active constituents of the studied fractions were vanillic acid, hyperoside, p‐coumaric acid, quercetin, and chrysoeriol. The findings showed the active bioassay‐directed fractions, as well compounds to the best of our knowledge for the first time, suggesting further future biological, pharmacological, and toxicological evaluations both in vitro and in vivo.
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (5) , 631-653
Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives
In recent years, there has been an increase in skin cancers due to external factors, especially environmental factors, and studies on treatment alternatives have gained importance. Nanomaterials are common, from sunscreen formulas to formulations designed to treat skin cancers at various stages. Using bioactives has multiple effects in treating skin cancers, which provides many advantages. In this regard, many phytochemicals gain importance with their antioxidant, anti-proliferative, anti-inflammatory, antiangiogenic, and analgesic effects. Their delivery with nanocarriers is on the agenda for phytochemicals to gain the targeted stability, effectiveness, and toxicity/safety properties. This review presents types of skin cancers, phytochemicals effective in skin cancers, and their nanocarrier-loaded studies from an up-to-date perspective.
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (5) , 631-653
Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives
In recent years, there has been an increase in skin cancers due to external factors, especially environmental factors, and studies on treatment alternatives have gained importance. Nanomaterials are common, from sunscreen formulas to formulations designed to treat skin cancers at various stages. Using bioactives has multiple effects in treating skin cancers, which provides many advantages. In this regard, many phytochemicals gain importance with their antioxidant, anti-proliferative, anti-inflammatory, antiangiogenic, and analgesic effects. Their delivery with nanocarriers is on the agenda for phytochemicals to gain the targeted stability, effectiveness, and toxicity/safety properties. This review presents types of skin cancers, phytochemicals effective in skin cancers, and their nanocarrier-loaded studies from an up-to-date perspective.
- 1 March 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (6) , 795-812
Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives
One of the most common malignancies in women, breast cancer accounts for nearly 25% of all cancer cases. Breast cancer is a diverse cancer form that exhibits variability in both morphology and molecular characteristics and is linked to numerous risk factors. Although various approaches and research are ongoing in the treatment and prevention of breast cancer, medication resistance in the current breast cancer treatment contributes to the disease's relapse and recurrence. Phytoactive molecules are the subject of growing research in both breast cancer prevention and treatment, but currently used conventional medicines and techniques limit their application. In recent years, significant advancements have been made in the field of nanotechnology, which has proven to be essential in the fight against drug resistance. The transport of synthetic and natural anticancer molecules via nanocarriers has recently been added to breast cancer therapy, greatly alleviating the constraints of the current approach. In light of these developments, interest in nano-delivery studies of phytoactive molecules has also increased. In this review, research of phytoactive molecules for breast cancers along with their clinical studies and nanoformulations, was presented from current and future perspectives.
- 1 March 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (6) , 795-812
Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives
One of the most common malignancies in women, breast cancer accounts for nearly 25% of all cancer cases. Breast cancer is a diverse cancer form that exhibits variability in both morphology and molecular characteristics and is linked to numerous risk factors. Although various approaches and research are ongoing in the treatment and prevention of breast cancer, medication resistance in the current breast cancer treatment contributes to the disease's relapse and recurrence. Phytoactive molecules are the subject of growing research in both breast cancer prevention and treatment, but currently used conventional medicines and techniques limit their application. In recent years, significant advancements have been made in the field of nanotechnology, which has proven to be essential in the fight against drug resistance. The transport of synthetic and natural anticancer molecules via nanocarriers has recently been added to breast cancer therapy, greatly alleviating the constraints of the current approach. In light of these developments, interest in nano-delivery studies of phytoactive molecules has also increased. In this review, research of phytoactive molecules for breast cancers along with their clinical studies and nanoformulations, was presented from current and future perspectives.
- Open Access
- 31 January 2025
- Published by Turkish Journal of Analytical Chemistry in Turkish Journal of Analytical Chemistry
- Vol. 7 (1) , 1-8
Investigation of antioxidant and anticholinesterase activity of Hypericum Perforatum L. extracts
Hypericum perforatum L. is widely known for its therapeutic properties, including wound healing, antispasmodic effects, and anxiety treatment. This study was examined the total phenolic and flavonoid content, antioxidant capacity, and anticholinesterase activity of aqueous, ethanolic, and water-ethanol extracts from the plant's aerial parts and also green chemistry and sustainability were also investigated. Extraction was performed under reflux at 60°C. The anticholinesterase effect of Hyperium perforatum L., which is known to be used in the treatment of neurological diseases such as coxalgia, paralysis, spastic paralysis, menopausal neurosis, spinal convulsion etc., was investigated in vitro [1]. Three different extracts were prepared as 100% ethanol, 50% ethanol-50% water and 100% water. The antioxidant activity of the prepared extracts was examined using Folin-Ciocalteu in terms of total phenolic-flavanoid content and then the anticholinesterase activity was investigated by Ellman method [2]. LC-HR-MS identified Rhamnocitrin as the most abundant compound in the water-ethanol extract, while Quercitrin and Hederagenin were descent in the ethanol extract. The ethanol extract demonstrated the highest total flavonoid content and enzyme inhibition rates, especially for AChE (65%) and BChE (75%). In contrast, the water extract had the highest phenolic content but lower enzyme inhibition, especially for BChE (16%). Greenness metrics analysis demonstrated superior recyclability for the aqueous extract, earning it the highest score in sustainability. In general, the ethanol extract exhibited the most potent biological activity, while the aqueous extract excelled in green chemistry principles. These findings support the potential of H. perforatum extracts for further development in natural product research.
- 31 January 2025
- Published by Turkish Journal of Analytical Chemistry in Turkish Journal of Analytical Chemistry
- Vol. 7 (1) , 1-8
Open AccessInvestigation of antioxidant and anticholinesterase activity of Hypericum Perforatum L. extracts
Hypericum perforatum L. is widely known for its therapeutic properties, including wound healing, antispasmodic effects, and anxiety treatment. This study was examined the total phenolic and flavonoid content, antioxidant capacity, and anticholinesterase activity of aqueous, ethanolic, and water-ethanol extracts from the plant's aerial parts and also green chemistry and sustainability were also investigated. Extraction was performed under reflux at 60°C. The anticholinesterase effect of Hyperium perforatum L., which is known to be used in the treatment of neurological diseases such as coxalgia, paralysis, spastic paralysis, menopausal neurosis, spinal convulsion etc., was investigated in vitro [1]. Three different extracts were prepared as 100% ethanol, 50% ethanol-50% water and 100% water. The antioxidant activity of the prepared extracts was examined using Folin-Ciocalteu in terms of total phenolic-flavanoid content and then the anticholinesterase activity was investigated by Ellman method [2]. LC-HR-MS identified Rhamnocitrin as the most abundant compound in the water-ethanol extract, while Quercitrin and Hederagenin were descent in the ethanol extract. The ethanol extract demonstrated the highest total flavonoid content and enzyme inhibition rates, especially for AChE (65%) and BChE (75%). In contrast, the water extract had the highest phenolic content but lower enzyme inhibition, especially for BChE (16%). Greenness metrics analysis demonstrated superior recyclability for the aqueous extract, earning it the highest score in sustainability. In general, the ethanol extract exhibited the most potent biological activity, while the aqueous extract excelled in green chemistry principles. These findings support the potential of H. perforatum extracts for further development in natural product research.
- Open Access
- 27 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (2) , 167
Production of Prophylactic Nanoformulation for Dental Caries and Investigation of Its Effectiveness by In Vitro and In Silico Methods
Background/Objectives: This study aimed to develop cinnamon bark essential oil (CEO), orange peel essential oil(OEO) and the combination of these two essential oils (OEO-CEO) loaded PLGA nanoparticles to prevent dental caries and to investigate their effectiveness in silico and in vitro methods. Methods: EO loaded PLGA nanoparticles were produced by single emulsion method. Detailed characterization studies were performed using different methods, and the controlled release profile was obtained. The antibacterial activity of the developed formulations was investigated on S. mutans and L. casei strains by in vitro and in silico methods. Additionally, the interaction mechanisms of EOs with DNA were evaluated. Results: Our findings showed that the average droplet size of EO-loaded PLGA nanoparticles varied between 243.1 ± 0.60 nm and 219 ± 4.49 nm, while PdI values varied between 0.069 ± 0.039 and 0.032 ± 0.01. In addition, the developed nanoparticles had high encapsulation efficiency (85.14% to 66.28%) and released the active ingredient in a continuous and controlled manner. Ames test showed that the genotoxicity of EOs was eliminated due to the encapsulation of EOs in PLGA nanoparticles and antibacterial tests showed that OEO-CEO-loaded PLGA nanoparticles were effective on L. casei and S. mutans. The antibacterial activity of EOs was also supported by in silico studies. Finally, it was revealed that EOs showed potential as antibacterial agents by interacting with DNA. Conclusions: The results showed that OEO-CEO-loaded PLGA nanoparticles have the potential to be a suitable nanoformulation for developing mouthwash or toothpaste for the prevention and treatment of dental caries.
- 27 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (2) , 167
Open AccessProduction of Prophylactic Nanoformulation for Dental Caries and Investigation of Its Effectiveness by In Vitro and In Silico Methods
Background/Objectives: This study aimed to develop cinnamon bark essential oil (CEO), orange peel essential oil(OEO) and the combination of these two essential oils (OEO-CEO) loaded PLGA nanoparticles to prevent dental caries and to investigate their effectiveness in silico and in vitro methods. Methods: EO loaded PLGA nanoparticles were produced by single emulsion method. Detailed characterization studies were performed using different methods, and the controlled release profile was obtained. The antibacterial activity of the developed formulations was investigated on S. mutans and L. casei strains by in vitro and in silico methods. Additionally, the interaction mechanisms of EOs with DNA were evaluated. Results: Our findings showed that the average droplet size of EO-loaded PLGA nanoparticles varied between 243.1 ± 0.60 nm and 219 ± 4.49 nm, while PdI values varied between 0.069 ± 0.039 and 0.032 ± 0.01. In addition, the developed nanoparticles had high encapsulation efficiency (85.14% to 66.28%) and released the active ingredient in a continuous and controlled manner. Ames test showed that the genotoxicity of EOs was eliminated due to the encapsulation of EOs in PLGA nanoparticles and antibacterial tests showed that OEO-CEO-loaded PLGA nanoparticles were effective on L. casei and S. mutans. The antibacterial activity of EOs was also supported by in silico studies. Finally, it was revealed that EOs showed potential as antibacterial agents by interacting with DNA. Conclusions: The results showed that OEO-CEO-loaded PLGA nanoparticles have the potential to be a suitable nanoformulation for developing mouthwash or toothpaste for the prevention and treatment of dental caries.